WAM
MYGN icon

Weiss Asset Management’s Myriad Genetics MYGN Stock Holding History

Weiss Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-174,844
Closed -$787K – 774
2026
Q1 		$787K Buy
+174,844
New +$911K 0.01% 360
2025
Q4 		– Sell
-130,343
Closed -$942K – 763
2025
Q3 		$942K Buy
+130,343
New +$774K 0.01% 364

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Weiss Asset Management's MYGN Position: Q2 2026 in Review

Weiss Asset Management sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 174,844 shares — an estimated $787K sold.

Weiss Asset Management first reported a position in MYGN in Q3 2025 and held it in 2 quarters. The position peaked at $942K in Q3 2025. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Weiss Asset Management reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 174,844 Myriad Genetics shares in Q2 2026, an estimated $787K.
  • Weiss Asset Management first reported a position in Myriad Genetics in Q3 2025 and held it in 2 quarters.
  • Weiss Asset Management's Myriad Genetics position peaked at $942K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.